326 related articles for article (PubMed ID: 32249630)
1. An overview of the available treatments for chronic cavitary pulmonary aspergillosis.
Sehgal IS; Dhooria S; Muthu V; Prasad KT; Agarwal R
Expert Rev Respir Med; 2020 Jul; 14(7):715-727. PubMed ID: 32249630
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.
Alastruey-Izquierdo A; Cadranel J; Flick H; Godet C; Hennequin C; Hoenigl M; Kosmidis C; Lange C; Munteanu O; Page I; Salzer HJF;
Respiration; 2018; 96(2):159-170. PubMed ID: 29982245
[TBL] [Abstract][Full Text] [Related]
3. Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis.
Sehgal IS; Dhooria S; Prasad KT; Muthu V; Aggarwal AN; Chakrabarti A; Agarwal R
Mycoses; 2021 Sep; 64(9):1053-1061. PubMed ID: 34031920
[TBL] [Abstract][Full Text] [Related]
4. Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.
Evans TJ; Lawal A; Kosmidis C; Denning DW
Semin Respir Crit Care Med; 2024 Feb; 45(1):88-101. PubMed ID: 38154471
[TBL] [Abstract][Full Text] [Related]
5. Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
Bongomin F; Maguire N; Moore CB; Felton T; Rautemaa-Richardson R
Mycoses; 2019 Mar; 62(3):217-222. PubMed ID: 30570179
[TBL] [Abstract][Full Text] [Related]
6. Multi-azole resistance in Aspergillus fumigatus.
Howard SJ; Webster I; Moore CB; Gardiner RE; Park S; Perlin DS; Denning DW
Int J Antimicrob Agents; 2006 Nov; 28(5):450-3. PubMed ID: 17034993
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough pulmonary Aspergillus fumigatus infection with multiple triazole resistance in a Spanish patient with chronic myeloid leukemia.
Mellado E; De La Camara R; Buendía B; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2013 Jan; 30(1):64-8. PubMed ID: 22986228
[TBL] [Abstract][Full Text] [Related]
8. Graded isavuconazole introduction in a patient with voriconazole allergy.
Morales MK; Harris C; Shoham S
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28851131
[TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of Chronic Pulmonary Aspergillosis With Isavuconazole.
Guillen Vera D; Ruiz Ruigómez M; García Moguel I; Morales Ruiz R; Corbella L; Fernández Rodríguez C
J Investig Allergol Clin Immunol; 2019; 29(6):459-460. PubMed ID: 31172952
[No Abstract] [Full Text] [Related]
10. Emergence of azole resistant-
Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
[No Abstract] [Full Text] [Related]
11. Instillation of Amphotericin B by bronchoscopy combined with systemic voriconazole in advanced non-small cell lung cancer patients with chronic cavitary pulmonary aspergillosis: A case series and literature review.
Wu H; Xiong X; Han Q; Zhuo K; Wang K; Cheng D
J Mycol Med; 2023 Aug; 33(3):101385. PubMed ID: 37031653
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Ullmann AJ; Aguado JM; Arikan-Akdagli S; Denning DW; Groll AH; Lagrou K; Lass-Flörl C; Lewis RE; Munoz P; Verweij PE; Warris A; Ader F; Akova M; Arendrup MC; Barnes RA; Beigelman-Aubry C; Blot S; Bouza E; Brüggemann RJM; Buchheidt D; Cadranel J; Castagnola E; Chakrabarti A; Cuenca-Estrella M; Dimopoulos G; Fortun J; Gangneux JP; Garbino J; Heinz WJ; Herbrecht R; Heussel CP; Kibbler CC; Klimko N; Kullberg BJ; Lange C; Lehrnbecher T; Löffler J; Lortholary O; Maertens J; Marchetti O; Meis JF; Pagano L; Ribaud P; Richardson M; Roilides E; Ruhnke M; Sanguinetti M; Sheppard DC; Sinkó J; Skiada A; Vehreschild MJGT; Viscoli C; Cornely OA
Clin Microbiol Infect; 2018 May; 24 Suppl 1():e1-e38. PubMed ID: 29544767
[TBL] [Abstract][Full Text] [Related]
13. Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria.
Rodriguez-Goncer I; Harris C; Kosmidis C; Muldoon EG; Newton PJ; Denning DW
Int J Antimicrob Agents; 2018 Aug; 52(2):258-264. PubMed ID: 29906567
[TBL] [Abstract][Full Text] [Related]
14. Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature.
Pena TA; Soubani AO; Samavati L
Lung; 2011 Apr; 189(2):167-72. PubMed ID: 21327836
[TBL] [Abstract][Full Text] [Related]
15. Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis.
Zheng X; Shao J; Xu J
Am J Med Sci; 2016 Aug; 352(2):218. PubMed ID: 27524222
[No Abstract] [Full Text] [Related]
16. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.
Dannaoui E; Meletiadis J; Tortorano AM; Symoens F; Nolard N; Viviani MA; Piens MA; Lebeau B; Verweij PE; Grillot R; And The Ebga Network
J Med Microbiol; 2004 Feb; 53(Pt 2):129-134. PubMed ID: 14729934
[TBL] [Abstract][Full Text] [Related]
18. Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre.
Osborne W; Fernandes M; Brooks S; Grist E; Sayer C; Hansell DM; Wilson R; Shah A; Loebinger MR
Clin Respir J; 2020 Jun; 14(6):571-577. PubMed ID: 32077238
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary aspergillosis: recent advances.
Thompson GR; Patterson TF
Semin Respir Crit Care Med; 2011 Dec; 32(6):673-81. PubMed ID: 22167395
[TBL] [Abstract][Full Text] [Related]
20. Cavernoscopic Views of a Pleural Aspergillosis.
Ocak S; d'Odémont JP
Am J Respir Crit Care Med; 2021 Jan; 203(1):e1-e2. PubMed ID: 33021398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
